Wells Fargo’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $831 | Sell |
335
-20,237
| -98% | -$50.2K | ﹤0.01% | 5865 |
|
|
2025
Q1 | $31.9K | Buy |
20,572
+453
| +2% | +$702 | ﹤0.01% | 5092 |
|
|
2024
Q4 | $43.1K | Buy |
20,119
+5,932
| +42% | +$12.7K | ﹤0.01% | 5043 |
|
|
2024
Q3 | $61.7K | Buy |
14,187
+469
| +3% | +$2.04K | ﹤0.01% | 4866 |
|
|
2024
Q2 | $63.9K | Buy |
13,718
+13,439
| +4,817% | +$62.6K | ﹤0.01% | 4829 |
|
|
2024
Q1 | $1.42K | Buy |
279
+5
| +2% | +$25 | ﹤0.01% | 5692 |
|
|
2023
Q4 | $770 | Sell |
274
-86
| -24% | -$242 | ﹤0.01% | 5846 |
|
|
2023
Q3 | $1.03K | Buy |
360
+113
| +46% | +$324 | ﹤0.01% | 5817 |
|
|
2023
Q2 | $1.25K | Sell |
247
-394
| -61% | -$1.99K | ﹤0.01% | 5972 |
|
|
2023
Q1 | $1.21K | Buy |
641
+402
| +168% | +$759 | ﹤0.01% | 6002 |
|
|
2022
Q4 | $430 | Sell |
239
-496
| -67% | -$892 | ﹤0.01% | 6097 |
|
|
2022
Q3 | $1K | Sell |
735
-16
| -2% | -$22 | ﹤0.01% | 5943 |
|
|
2022
Q2 | $1K | Sell |
751
-1,179
| -61% | -$1.57K | ﹤0.01% | 6162 |
|
|
2022
Q1 | $6K | Sell |
1,930
-8,075
| -81% | -$25.1K | ﹤0.01% | 6061 |
|
|
2021
Q4 | $53K | Sell |
10,005
-3,663
| -27% | -$19.4K | ﹤0.01% | 5494 |
|
|
2021
Q3 | $115K | Buy |
13,668
+289
| +2% | +$2.43K | ﹤0.01% | 5039 |
|
|
2021
Q2 | $163K | Sell |
13,379
-656,475
| -98% | -$8M | ﹤0.01% | 4814 |
|
|
2021
Q1 | $16.3M | Buy |
669,854
+6,221
| +0.9% | +$151K | ﹤0.01% | 1765 |
|
|
2020
Q4 | $21.3M | Buy |
663,633
+201,246
| +44% | +$6.45M | 0.01% | 1509 |
|
|
2020
Q3 | $14M | Buy |
462,387
+177,855
| +63% | +$5.38M | ﹤0.01% | 1653 |
|
|
2020
Q2 | $12M | Buy |
284,532
+266,336
| +1,464% | +$11.2M | ﹤0.01% | 1700 |
|
|
2020
Q1 | $454K | Buy |
+18,196
| New | +$454K | ﹤0.01% | 3985 |
|